The efficacy and safety of first-line and salvage therapies with bevacizumab combination chemotherapy regimens in metastatic colorectal cancer: A retrospective ASMO experience.

dc.authoridbenekli, mustafa/0000-0003-3184-4946
dc.authoridElkıran, Emin Tamer/0000-0001-6681-7249
dc.authoridOzturk, Banu/0000-0003-0290-8787
dc.authorwosidbenekli, mustafa/AAE-4555-2020
dc.authorwosidElkıran, Emin Tamer/ABI-8192-2020
dc.authorwosidGumus, Mahmut/C-7135-2008
dc.authorwosidGumus, Mahmut/HTO-4176-2023
dc.authorwosidunal, olcun umit/IST-6684-2023
dc.authorwosidOzturk, Banu/AAD-4358-2019
dc.contributor.authorYildiz, Ramazan
dc.contributor.authorBuyukberber, Suleyman
dc.contributor.authorKoca, Dogan
dc.contributor.authorKorai, Lokman
dc.contributor.authorCiltas, Aydin
dc.contributor.authorUnal, Olcun Umit
dc.contributor.authorGumus, Mahmut
dc.date.accessioned2024-08-04T21:02:03Z
dc.date.available2024-08-04T21:02:03Z
dc.date.issued2013
dc.departmentİnönü Üniversitesien_US
dc.description49th Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO) -- MAY 31-JUN 04, 2013 -- Chicago, ILen_US
dc.description.abstract[Abstract Not Available]en_US
dc.description.sponsorshipAmer Soc Clin Oncolen_US
dc.identifier.issn0732-183X
dc.identifier.issn1527-7755
dc.identifier.issue15en_US
dc.identifier.urihttps://hdl.handle.net/11616/104431
dc.identifier.volume31en_US
dc.identifier.wosWOS:000335419603655en_US
dc.identifier.wosqualityQ1en_US
dc.indekslendigikaynakWeb of Scienceen_US
dc.language.isoenen_US
dc.publisherLippincott Williams & Wilkinsen_US
dc.relation.ispartofJournal of Clinical Oncologyen_US
dc.relation.publicationcategoryKonferans Öğesi - Uluslararası - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.subject[No Keywords]en_US
dc.titleThe efficacy and safety of first-line and salvage therapies with bevacizumab combination chemotherapy regimens in metastatic colorectal cancer: A retrospective ASMO experience.en_US
dc.typeConference Objecten_US

Dosyalar